Objects related with this person

Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine.

Interaction of PRMT1 with BTG/TOB proteins in cell signalling: molecular analysis and functional aspects.

Potential mechanisms of resistance to cytarabine in AML patients.

In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia.

Factors predictive of early death in patients receiving high-dose CHOP (ACVB regimen) for aggressive non-Hodgkin's lymphoma: a GELA study.

Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients.

Nucleoside analogues and nucleobases in cancer treatment.

Thalidomide in patients with advanced multiple myeloma: a study of 83 patients--report of the Intergroupe Francophone du Myélome (IFM).

Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance.

[The role of gemcitabine in hematology]

Influence of p53 and p21(WAF1) expression on sensitivity of cancer cells to cladribine.

Microtubule-associated parameters as predictive markers of docetaxel activity in advanced breast cancer patients: results of a pilot study.

A new P-glycoprotein inhibitor from the caper spurge (Euphorbia lathyris).

Outcome in relation to treatment modalities in 48 patients with localized gastric MALT lymphoma: a retrospective study of patients treated during 1976-2001.

Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine.

Jatrophane diterpenes as P-glycoprotein inhibitors. First insights of structure-activity relationships and discovery of a new, powerful lead.

In B-cell chronic lymphocytic leukemias, 7q21 translocations lead to overexpression of the CDK6 gene.

Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies.

Sensitization of ara-C-resistant lymphoma cells by a pronucleotide analogue.

Pyrimidine nucleoside analogs in cancer treatment.

Modified jatrophane diterpenes as modulators of multidrug resistance from Euphorbia dendroides L.

In vitro susceptibility of CD4(+) and CD8(+) T cell subsets to fludarabine.

EPO-906 (Novartis).

Frameshift mutation in the Dok1 gene in chronic lymphocytic leukemia.

Jatrophane diterpenes as modulators of multidrug resistance. Advances of structure-activity relationships and discovery of the potent lead pepluanin A.

5 -(3 )-nucleotidase mRNA levels in blast cells are a prognostic factor in acute myeloid leukemia patients treated with cytarabine.

Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene.

Maintenance therapy with a monthly injection of alemtuzumab prolongs response duration in patients with refractory B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL).

Structure-activity relationships for euphocharacins A-L, a new series of jatrophane diterpenes, as inhibitors of cancer cell P-glycoprotein.

Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug.

Problems related to resistance to cytarabine in acute myeloid leukemia.

Antimitotic activity of 5-hydroxy-7-methoxy-2-phenyl-4-quinolones.

Second autologous transplantation after failure of a first autologous transplant in 18 patients with non-Hodgkin's lymphoma.

Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations.

The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma.

Evaluation of gemcitabine in relapsed or refractory multiple myeloma.

Resistance to microtubule-targeted cytotoxins in a K562 leukemia cell variant associated with altered tubulin expression and polymerization.

Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma: a cross-sectional study in Lyon, France.

Substrate cycles and drug resistance to 1-beta-D-arabinofuranosylcytosine (araC).

Chemoresistance in non-small cell lung cancer.

Expression of class III beta tubulin in non-small cell lung cancer is correlated with resistance to taxane chemotherapy.

[Metabolism, mechanism of action and resistance to cytotoxic nucleoside analogues]

cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer.

Expression of class III {beta}-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy.

Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells.

The prognostic value of cN-II and cN-III enzymes in adult acute myeloid leukemia.

Class III beta-tubulin expression in tumor cells predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel.

A p21/WAF1 mutation favors the appearance of drug resistance to paclitaxel in human noncancerous epithelial mammary cells.

Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells.

The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.



Related people:
Fatima Cardoso
Cyril Berthet
Philippe Arnaud
Philippe Moreau
Alain Puisieux
Isabelle Tigaud
Gilles Salles
Ernesto Fattorusso
Martine Ffrench
Isabelle Treilleux
Fabien Calvo
Francoise Berger
Xavier Thomas
Sandrine Hayette
Mirta Giordano
Romina Gamberale
Gwenaëlle Conseil
Carlos María Galmarini
Marilyn L Clarke
Lars Jordheim
Cheryl L Santos
Emeline Cros
John R Mackey
Charles Dumontet
Françoise Berger
Bertrand Coiffier
Olivier Hequet
Giovanni Appendino
Mauro Ballero
Kathryn Graham
Marianne Paesmans
Felix Reyes
Ruth Rimokh
Muriel Rabilloud
Orazio Taglialatela-Scafati
Denis Larsimont
Angelo Di Leo
Thierry Facon
Mary Callanan
Jean Luc Harousseau
Alain Duhamel
Catherine Thieblemont
Fadhela Bouafia
Daniel Espinouse
André Bosly
Enrico Mercalli
Philippe Rousselot
Olov Sterner
Pascale Felman
Sophie Gazzo
Evelyne Callet-Bauchu
Gilles Gosselin
Gérald Marit
Martine J Piccart
Christian Berthou
Michel Attal
Bernard Grosbois
Carlos M Galmarini
Nicolas Mounier
Gabriella Corea
Virginia Lanzotti
Pierre-Noël Simon
Attilio Di Pietro
Olivier Casasnovas
Thierry Molina
Ahcène Boumendjel
Nicole Falette
Marie Christine Bissery
Pierre Noël Simon
Denis Barron
David Gancberg
Jean-Pierre Magaud
Jean-Pierre Rouault
Christian Perigaud
Colette Dehay
Kamal Wahbi
Assia El Jafaari
Jacques-Olivier Bay
Carla Della Porta
Chantal Bernard-Marty
Arlette Fellous
Nathalie Voorzanger
Corinne Duguet
Ibrahim Yakoub-Agha
Válerie Delannoy
Thierney Lamy
Charly Dauriac
Véronique Dorvaux
Matthieu Monconduit
Josette Arcache
Agnès Lukaszewicz
Jean Nicolas Munck
Frank Morschauser
Daniele Simon
Oumédaly Reman
Assia El Jafaari
Fabienne Guéhenneux
Valérie Revol
Christiane Samarut
Assia El Jaffari